TUESDAY, Sept. 3, 2024 (HealthDay News) — The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study rules out one possible problem — using semaglutide does not increase a person’s risk of depression or suicide,Continue Reading
TUESDAY, Sept. 3, 2024 (HealthDay News) — Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health. But they still need to eat a high-quality diet if they want to maintain their well-being while they shed pounds, says a doctor with the UniversityContinue Reading
FRIDAY, Aug.30, 2024 (HealthDay News) — New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of semaglutide. In multiple new data analyses, the drugs appeared to cut people’s odds for heart failureContinue Reading
TUESDAY, Aug. 27, 2024 (HealthDay News) — Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers. The new 2.5 milligram (mg) and 5 mg weekly dose vials differ fromContinue Reading
TUESDAY, Aug. 27, 2024 (HealthDay News) — Good sleep is important for the health of overweight men and women, a new study shows. Heavy-set people who stay awake too late tend to have a higher risk of metabolic syndrome — a cluster of conditions that increase the risk of heartContinue Reading
TUESDAY, Aug. 27, 2024 (HealthDay News) — New Medicare rules could make 3.6 million Americans — or even more — eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds. Under the new rules, the government will pay for Wegovy treatment if a person with high BMIContinue Reading
THURSDAY, Aug. 21, 2024 (HealthDay News) — Type 2 diabetes increased by nearly 20% in the United States between 2012 and 2022, with age, race, income level, obesity and lack of exercise all playing a role in the metabolic disease’s spread, a new study reports. “Diabetes is increasing day by dayContinue Reading
TUESDAY, Aug. 20, 2024 (HealthDay News) — Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that an obese, prediabetic person will develop diabetes by 94%, a new trial shows. The three-year-long trial, funded by the drugs’ maker, Eli Lilly, alsoContinue Reading
MONDAY, Aug. 19, 2024 (HealthDay News) — “Stealth” foods are sneaking saturated fat and added sugars into even the strictest diets, a new study shows. Most saturated fats and added sugars come from well-known sources – soft drinks, cheese, pizza, ice cream, cakes and pies. But even supposedly healthy foodsContinue Reading
WEDNESDAY, Aug. 14, 2024 (HealthDay News) — Americans continue to rank dead last in life expectancy among English-speaking countries, a new study finds. People in the United States more often fall prey at younger ages to accidental deaths, homicides and chronic diseases, researchers reported Aug. 13 in the BMJ OpenContinue Reading